Accueil>>Signaling Pathways>> PI3K/Akt/mTOR Signaling>> Akt>>24-Methylenecycloartanyl ferulate

24-Methylenecycloartanyl ferulate

Catalog No.GC64670

Le férulate de 24-méthylènecycloartanyle est un composé γ-oryzanol. Le férulate de 24-méthylènecycloartanyle favorise l'expression de la parvine-bêta dans les cellules cancéreuses du sein humain. Le férulate de 24-méthylènecycloartanyle est un inhibiteur potentiel d'Akt1 compétitif pour l'ATP (EC50 = 33,3 μM).

Products are for research use only. Not for human use. We do not sell to patients.

24-Methylenecycloartanyl ferulate Chemical Structure

Cas No.: 469-36-3

Taille Prix Stock Qté
5 mg
351,00 $US
En stock
10 mg
621,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

24-Methylenecycloartanyl ferulate is a γ-oryzanol compound. 24-Methylenecycloartanyl ferulate promotes parvin-beta expression in human breast cancer cells. 24-Methylenecycloartanyl ferulate is a potential ATP-competitive Akt1 inhibitor (EC50= 33.3μM)[1].

[1]. Heon Woong Kim, et al. 24-Methylenecycloartanyl ferulate, a major compound of γ-oryzanol, promotes parvin-beta expression through an interaction with peroxisome proliferator-activated receptor-gamma 2 in human breast cancer cells. Biochem Biophys Res Commun. 2015 Dec 25;468(4):574-9.

Avis

Review for 24-Methylenecycloartanyl ferulate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 24-Methylenecycloartanyl ferulate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.